Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: Protocol for a phase IV, single-arm, open-label trial

  1. Gil, E.
  2. Garcia-Alonso, F.
  3. Boldeanu, A.
  4. Baleeiro Teixeira, T.
  5. Tordera, V.
  6. Viciedo, R.P.
  7. Ribas, J.D.
  8. Montes, J.M.
  9. Lauffer, J.C.
  10. Murugarrem, S.R.
  11. García, S.O.
  12. Mora, F.
  13. López, P.A.
  14. Navas, A.F.
  15. Pinto, A.M.G.
  16. Martínez, R.
  17. Castrillo, C.G.
  18. Toledo, F.
  19. Vieta, E.
  20. González, E.
  21. Franco, M.
  22. Drasovean, N.V.
  23. Dahl, N.H.
  24. Skagen, B.
  25. Zilles, D.
  26. Zwanzger, P.
  27. Juckel, G.
  28. Kahl, K.G.
  29. Messer, T.
  30. Kasper, S.
  31. Erakutsi egile guztiak +
Aldizkaria:
BMJ Open

ISSN: 2044-6055

Argitalpen urtea: 2018

Alea: 8

Zenbakia: 10

Mota: Artikulua

DOI: 10.1136/BMJOPEN-2017-020242 GOOGLE SCHOLAR lock_openSarbide irekia editor